TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
KR |
|
Q
|
Qingdao TGOOD Electric Co Ltd
SZSE:300001
|
CN |
|
Guangdong Huicheng Vacuum Technology Co Ltd
SZSE:301392
|
CN |
|
Tiong Seng Holdings Ltd
SGX:BFI
|
SG |
|
A
|
Administradora de Activos Fibra Inn SC
BMV:FINN13
|
MX |
|
Novozymes A/S
CSE:NSIS B
|
DK |
|
Prime US REIT
SGX:OXMU
|
SG |
|
Miyakoshi Holdings Inc
TSE:6620
|
JP |
|
C
|
Cathay Chemical Works Inc
TWSE:1713
|
TW |
|
Macatawa Bank Corp
NASDAQ:MCBC
|
US |
|
G
|
Ganfeng Lithium Co Ltd
HKEX:1772
|
CN |
|
C
|
Chevron Corp
XHAM:CHV
|
US |
|
Yourgene Health PLC
LSE:YGEN
|
UK |
|
B
|
BusinessOn Communication Co Ltd
KOSDAQ:138580
|
KR |
|
Baylin Technologies Inc
TSX:BYL
|
CA |
TiumBio Co Ltd
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.